BRG
OMIC

Bay Rivers Group’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Bay Rivers Group’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-467
Closed -$6.44K – 83
2023
Q4 		$6.44K Hold
467
– – ﹤0.01% 71
2023
Q3 		$5.33K Hold
467
– – ﹤0.01% 65
2023
Q2 		$11.6K Hold
467
– – 0.01% 67
2023
Q1 		$16.9K Hold
467
– – 0.01% 62
2022
Q4 		$28.1K Hold
467
– – 0.03% 60
2022
Q3 		$35K Hold
467
– – 0.04% 60
2022
Q2 		$53K Buy
+467
New +$54.8K 0.05% 61

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Bay Rivers Group's OMIC Position: Q1 2024 in Review

Bay Rivers Group sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q1 2024, closing a stake of 467 shares — an estimated $6.44K sold.

Bay Rivers Group first reported a position in OMIC in Q2 2022 and held it in 7 quarters. The position peaked at $53K in Q2 2022. 42 funds tracked by Wall St. Rank hold OMIC as of Q1 2024.

  • Bay Rivers Group reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Bay Rivers Group sold 467 Singular Genomics Systems, Inc. Common Stock shares in Q1 2024, an estimated $6.44K.
  • Bay Rivers Group first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2022 and held it in 7 quarters.
  • Bay Rivers Group's Singular Genomics Systems, Inc. Common Stock position peaked at $53K in Q2 2022.
  • 42 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q1 2024.

Based on Bay Rivers Group's 13F filing for Q1 2024, filed 22 Apr 2024.